IRIS
CHISARI, CLARA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.685
EU - Europa 1.311
AS - Asia 1.075
AF - Africa 277
SA - Sud America 225
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 5.578
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.617
SG - Singapore 650
IT - Italia 483
IE - Irlanda 335
CN - Cina 307
BR - Brasile 206
CI - Costa d'Avorio 201
RU - Federazione Russa 168
UA - Ucraina 115
CA - Canada 63
SN - Senegal 62
DE - Germania 57
VN - Vietnam 32
FR - Francia 28
GB - Regno Unito 23
NL - Olanda 21
SE - Svezia 20
FI - Finlandia 17
IN - India 17
TR - Turchia 16
CH - Svizzera 11
UZ - Uzbekistan 9
JP - Giappone 8
HK - Hong Kong 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
NG - Nigeria 6
VE - Venezuela 6
AT - Austria 5
KR - Corea 5
PL - Polonia 5
AR - Argentina 4
GR - Grecia 4
PE - Perù 4
BG - Bulgaria 3
EC - Ecuador 3
IQ - Iraq 3
MX - Messico 3
PK - Pakistan 3
ZA - Sudafrica 3
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
EU - Europa 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
BD - Bangladesh 1
CO - Colombia 1
DO - Repubblica Dominicana 1
ES - Italia 1
HR - Croazia 1
ID - Indonesia 1
IM - Isola di Man 1
IR - Iran 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SV - El Salvador 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.578
Salva come PNG Salva come JPEG
Città #
Santa Clara 661
Chandler 445
Singapore 376
Dublin 327
Chicago 215
Abidjan 200
Boardman 138
Catania 134
Jacksonville 105
Ashburn 97
Civitanova Marche 90
Cambridge 80
Lawrence 79
Andover 76
Dakar 62
Nanjing 60
Saint Petersburg 60
Des Moines 48
Toronto 47
Bremen 32
Dong Ket 26
Wilmington 24
Los Angeles 19
São Paulo 18
Nanchang 17
Shenyang 17
Beijing 16
Council Bluffs 16
Milan 16
Rome 14
Hebei 13
Belo Horizonte 11
Redwood City 11
Bernareggio 10
Kiev 10
Lappeenranta 10
Ottawa 10
San Francisco 10
San Mateo 10
Seattle 10
Giarre 8
Houston 8
Moscow 8
Helsinki 7
Istanbul 7
Munich 7
Palermo 7
Pune 7
Rio de Janeiro 7
Tianjin 7
Abu Dhabi 6
Amsterdam 6
Guangzhou 6
Hong Kong 6
Padova 6
Tokyo 6
Abuja 5
Changsha 5
Jiaxing 5
Jinan 5
Kunming 5
Porto Alegre 5
Pozzallo 5
St Louis 5
Strasbourg 5
Vicenza 5
Washington 5
Zhengzhou 5
Bari 4
Brasília 4
Brno 4
Civitavecchia 4
Edinburgh 4
Hanoi 4
Irpin 4
Shanghai 4
Shenzhen 4
Sorocaba 4
Bengaluru 3
Boydton 3
Contagem 3
Den Haag 3
Fortaleza 3
Frankfurt Am Main 3
Genoa 3
Hangzhou 3
London 3
Mascalucia 3
Ningbo 3
Salvador 3
Samara 3
San Giovanni la Punta 3
Seoul 3
São José dos Campos 3
Tortora 3
Woodbridge 3
Agrigento 2
Amman 2
Arzano 2
Baku 2
Totale 3.891
Salva come PNG Salva come JPEG
Nome #
The ocular ecosystem in the discoid lupus erythematosus 192
After the sweet comes the bitter. Time to halt the diabetic neuropathy epidemic 101
Aging eye microbiota in dry eye syndrome in patients treated with enterococcus faecium and saccharomyces boulardii 97
Amyotrophic lateral sclerosis: differential diagnosis with cervical myeloradiculopathy 93
Functional stress and microbiota eye in subjects with type 2 diabetes: a multifactorial approach 82
Microbiological Etiology of Chronic skin lesions in type 2 Diabetic Subjects 82
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 81
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 77
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 75
AMNIOTIC MEMBRANE USE IN TYPE 2 DIABETES PATIENTS WITH CHRONIC ULCERS: MICROBIOLOGICAL EVALUATION AND THERAPEUTIC BENEFITS 74
Functional Neurological disorders; those bizarre and painfull disconnections between brain and body 74
Prevalence and Incidence of Multiple Sclerosis in the City of Biancavilla 74
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset 73
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 73
Cancer risk assessment in multiple sclerosis patients in the Eastern Sicily 72
Retinal Thickness and Microvascular Pattern in Early Parkinson's Disease 72
Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study 71
An update on the safety of treating relapsing-remitting multiple sclerosis 70
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography 68
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 67
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management 67
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 66
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 66
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod 64
Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach 63
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab 62
The ocular surface in patients video display terminal (VDT) 62
Inpatient versus outpatient rehabilitation for multiple sclerosis patients: effects on disability and quality of life 61
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmartâ ¢â the FUTURE study 61
eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54 60
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study 60
Multiple Sclerosis in the Mount Etna region: possible role of volcanogenic trace elements 59
Etiology of chronic skin lesions in subjects with peripheral arterial disease 59
The clinical value of Coop/Wonca charts in assessment of HRQoL in a large cohort of relapsing-remitting multiple sclerosis patients: Results of a multicenter study 58
The effects of blood glucose regulation onn the microbiota ocular in Type II diabetic subjects 58
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 58
Risk factors for ocular surface disorders in patients with type 2 diabetes 58
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 58
Clinical bacteriological aspects of the Human Amniotic Membrane in the diabetic foot. A case report 56
WII may improve physical abilities in multiple sclerosis: a randomized single blind study 55
Retinal Nerve Fiber Layer Thickness and Higher Relapse Frequency May Predict Poor Recovery after Optic Neuritis in MS Patients 55
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis 54
Early-Onset Alcohol Dependence and Multiple Sclerosis: Diagnostic Challenges 54
Microbiology synergism between tear substitutes and symbiotic treatment of patients with irritable bowel syndrome 53
An update on the pharmacological management of pain in patients with multiple sclerosis 53
Retinal thickness and microvascular pathway in Idiopathic Rapid eye movement sleep behaviour disorder and Parkinson's disease 53
Functional stress and alteration of the ocular surface in subjects video display terminal (VDT) 52
Microbiological characteristics of the ocular surface in the patients with discoid lupus erythematosus. 52
Toxoplasma gondii and multiple sclerosis: a population-based case–control study 52
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point 52
Pharmacoeconomics of synthetic therapies for multiple sclerosis 51
Treatment in worsening multiple sclerosis patients: new drugs are better than older ones? 50
Valutazione dell’efficacia clinica-batteriologica dell’ofloxacina e della levofloxacina nelle congiuntiviti batteriche 50
Static postural control disturbances among the different multiple sclerosis phenotypes: A Neurocom Balance Manager®evaluation study 50
Pain Following the Use of Anesthesia Formulation Among Individuals Undergoing Cataract Surgery: A Randomized Controlled Trial 50
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature 48
Prevalence and incidence of cognitive impairment in multiple sclerosis: a population-based survey in Catania, Sicily 48
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study 48
Esposizione ad elementi in tracce in aree ad alta incidenza di sclerosi multipla: un ruolo delle ceneri vulcaniche? 47
The efficacy of natalizumab and fingolimod on cognition in relapsing-remitting multiple sclerosis patients 47
Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis 47
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 47
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome' 45
The Cost-effectiveness of Sativex®: The Italian Experience Based on " in Resistant Multiple Sclerosis Spasticity: Discontinuation Study in a Large Population of Italian Patients, SA.FE. Study" 45
The mixture of bifidobacterium associated with fructooligosaccharides reduces the damage of the ocular surface 45
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study 45
REal-World effectIveNess of claDribine for patients with multiple sclerosis: a Sicilian multicentric experience (REWIND study) 44
Effects of Nintendo Wii Fit® balance exercise program on physical abilities and quality of life in Multiple Sclerosis patients 43
Measurement Of Retinal Nerve Fibre Layer Thickness In Clinical Isolated Syndrome 43
Rituximab for the treatment of multiple sclerosis: a review 43
A model-based study of internuclear ophthalmoparesis and ocular-motor fatigue in multiple sclerosis 42
Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic Insights 42
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients 42
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience 42
Pregnancy planning and management for women with multiple sclerosis: what has changed over the last 15 years? An Italian single-center experience 41
Objective evaluation of Nintendo Wii Fit Plus balance program training on postural stability in Multiple Sclerosis patients: a pilot study 41
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 41
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study 40
Palliative care in multiple sclerosis 39
Cilostazol reduces dry eye symptoms and improve walking distance in patients with peripheral artery disease 39
Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosis 39
Abnormal Eye Movements due to Disease of the Extraocular Muscles and Their Innervation 38
Factors driving delayed time to multiple sclerosis diagnosis: Results from a population-based study 38
Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study 38
Evolution of the concept of vascular dementia 38
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series 38
A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective 35
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study 35
Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis 35
Subclinical involvement of eye movements detected by video-based eye tracking in myasthenia gravis 34
Aging with multiple sclerosis: prevalence and profile of cognitive impairment 34
Modificazioni della superficie oculare nei soggetti videoterminalisti 34
Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies 33
Clinical and neurophysiological effects of fampridine in multiple sclerosis patients: a pilot study 32
A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols 30
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study 29
Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis 27
Hopelessness in Multiple Sclerosis: Psychological and Organic Correlates 26
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study) 26
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis 26
Totale 5.419
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.869
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 0 0 0 0 0 0 0 30 19
2020/2021335 15 21 26 11 102 9 28 8 21 19 34 41
2021/2022595 54 93 13 22 90 4 88 18 18 4 19 172
2022/20231.281 87 90 29 138 100 196 16 269 282 12 50 12
2023/2024708 34 155 41 32 27 159 11 56 8 12 109 64
2024/20252.296 61 376 137 148 499 399 120 60 222 270 4 0
Totale 5.796